Centogene announces its attendance at the 41st annual j.p. morgan healthcare meeting and fierce jpm week in san francisco

Cambridge, mass. and rostock, germany and berlin, dec. 28, 2022 (globe newswire) -- centogene n.v. (nasdaq: cntg), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that its management team, including chief executive officer kim stratton, will be attending the 41st annual j.p. morgan healthcare meeting, on january 9-12, 2023, in san francisco, u.s. the company will also be attending the fierce jpm week.
CNTG Ratings Summary
CNTG Quant Ranking